Quinoline-Based Hybrid Compounds with Antimalarial Activity
- PMID: 29257067
- PMCID: PMC6149725
- DOI: 10.3390/molecules22122268
Quinoline-Based Hybrid Compounds with Antimalarial Activity
Abstract
The application of quinoline-based compounds for the treatment of malaria infections is hampered by drug resistance. Drug resistance has led to the combination of quinolines with other classes of antimalarials resulting in enhanced therapeutic outcomes. However, the combination of antimalarials is limited by drug-drug interactions. In order to overcome the aforementioned factors, several researchers have reported hybrid compounds prepared by reacting quinoline-based compounds with other compounds via selected functionalities. This review will focus on the currently reported quinoline-based hybrid compounds and their preclinical studies.
Keywords: 4-aminoquinoline; 8-aminoquinoline; hybrid compound; infectious disease; malaria.
Conflict of interest statement
The authors declare no conflict of interest.
Figures










Similar articles
-
Quinoline-based antimalarial hybrid compounds.Bioorg Med Chem. 2015 Aug 15;23(16):5098-119. doi: 10.1016/j.bmc.2014.12.018. Epub 2014 Dec 19. Bioorg Med Chem. 2015. PMID: 25593097 Review.
-
Bisquinoline antimalarials: their role in malaria chemotherapy.Int J Parasitol. 1999 Mar;29(3):367-79. doi: 10.1016/s0020-7519(98)00217-3. Int J Parasitol. 1999. PMID: 10333319 Review.
-
In Vivo and In Vitro Optimization of Screening Antimalarial Hits toward Lead Molecules for Preclinical Development.J Med Chem. 2016 Nov 10;59(21):9668-9671. doi: 10.1021/acs.jmedchem.6b01486. Epub 2016 Oct 24. J Med Chem. 2016. PMID: 27775354
-
Hybrid molecules with potential in vitro antiplasmodial and in vivo antimalarial activity against drug-resistant Plasmodium falciparum.Med Res Rev. 2020 May;40(3):931-971. doi: 10.1002/med.21643. Epub 2019 Nov 6. Med Res Rev. 2020. PMID: 31692025 Review.
-
Quinoline hybrids and their antiplasmodial and antimalarial activities.Eur J Med Chem. 2017 Oct 20;139:22-47. doi: 10.1016/j.ejmech.2017.07.061. Epub 2017 Jul 27. Eur J Med Chem. 2017. PMID: 28800458 Review.
Cited by
-
The Anticancer Effect of a Novel Quinoline Derivative 91b1 through Downregulation of Lumican.Int J Mol Sci. 2022 Oct 29;23(21):13181. doi: 10.3390/ijms232113181. Int J Mol Sci. 2022. PMID: 36361971 Free PMC article.
-
Potential of Quinine Sulfate for COVID-19 Treatment and Its Safety Profile: Review.Clin Pharmacol. 2021 Dec 6;13:225-234. doi: 10.2147/CPAA.S331660. eCollection 2021. Clin Pharmacol. 2021. PMID: 34908881 Free PMC article. Review.
-
Design, Synthesis, and Anticancer and Antibacterial Activities of Quinoline-5-Sulfonamides.Molecules. 2024 Aug 26;29(17):4044. doi: 10.3390/molecules29174044. Molecules. 2024. PMID: 39274892 Free PMC article.
-
Preparation and in vitro bioactivity evaluation of N-heterocyclic-linked dihomooxacalix[4]arene derivatives.RSC Adv. 2019 Dec 13;9(70):41287-41297. doi: 10.1039/c9ra06876g. eCollection 2019 Dec 9. RSC Adv. 2019. PMID: 35540075 Free PMC article.
-
A simple and efficient copper-catalyzed three-component reaction to synthesize (Z)-1,2-dihydro-2-iminoquinolines.RSC Adv. 2021 Sep 29;11(50):31152-31158. doi: 10.1039/d1ra06330h. eCollection 2021 Sep 21. RSC Adv. 2021. PMID: 35496874 Free PMC article.
References
-
- Murugan K., Raichurkar A.V., Rahman F., Khan N., Iyer P.S. Synthesis and in vitro evaluation of novel 8-aminoquinoline—Pyrazolopyrimidine hybrids as potent antimalarial agents. Bioorg. Med. Chem. Lett. 2015;25:1100–1103. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical